Trials / Recruiting
RecruitingNCT07363551
Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression
Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression (OMIMYDep)- A Double-blind Randomized Controlled Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- China Medical University Hospital · Academic / Other
- Sex
- All
- Age
- 13 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a 12 week double blind RCT aimed to investigate the role of omega-3 fatty acids in patients with major depressive disorder
Detailed description
This is a 12 week double blind RCT aimed to investigate the role of omega-3 fatty acids in patients with major depressive disorder. Outcome measures including clinical symptoms, inflammation biomarkers and gut microbiota profiles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Omega-3 fatty acids | omega-3 fatty acids (EPA) |
| DIETARY_SUPPLEMENT | Placebo | soy bean oil |
Timeline
- Start date
- 2021-06-09
- Primary completion
- 2026-05-31
- Completion
- 2026-05-31
- First posted
- 2026-01-23
- Last updated
- 2026-01-26
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT07363551. Inclusion in this directory is not an endorsement.